Venbio Partners LLC
SEC exempt reporting adviser (venture capital exemption).
- Website
- HTTP://WWW.VENBIO.COM
- HQ
- CA
Venbio Partners LLC is a life sciences investment firm that partners with industry leaders to build medicines and technologies, with a focus on novel therapeutics for unmet medical needs. Its team includes co-founders, managing partners, a partner, an analyst, and finance leaders. Portfolio companies listed include Eyconis, Yarrow Bioscience, Attovia Therapeutics, Harmony Biosciences, Oak Hill Bio, and Pharvaris.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Series A, Growth, Series B |
| Sectors | Biotech | Not enough dated deals | Biotech, Healthtech, Medical devices, Life sciences and research tools |
| Regions | Not stated | Not enough dated deals | CA, MA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2012 | 3 | Biotech, Healthtech |
| 2013 | 4 | Biotech, Healthtech, Medical devices |
| 2014 | 4 | Biotech, Healthtech, Medical devices |
| 2015 | 7 | Biotech, Healthtech, Life sciences and research tools |
| 2016 | 2 | Healthtech, Biotech, Logistics |
| 2017 | 6 | Biotech, Healthtech, Medical devices |
| 2018 | 8 | Biotech, Healthtech, Medical devices |
| 2019 | 4 | Biotech, Healthtech, Consumer |
| 2020 | 5 | Biotech, Healthtech, Life sciences and research tools |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2012 | 0 | 0 | 0 | 0 | 2 |
| 2013 | 0 | 0 | 3 | 0 | 0 |
| 2014 | 0 | 0 | 2 | 0 | 1 |
| 2015 | 0 | 0 | 4 | 1 | 0 |
| 2016 | 0 | 0 | 0 | 0 | 2 |
| 2017 | 0 | 0 | 0 | 2 | 2 |
| 2018 | 0 | 0 | 2 | 2 | 3 |
| 2019 | 0 | 0 | 1 | 2 | 1 |
| 2020 | 0 | 0 | 2 | 1 | 2 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| venBio Global Strategic Fund V, L.P. venBio is a life sciences venture investor partnering with teams building novel therapeutics for unmet medical needs, helping companies plan development, clinical trials and potential acquisition partners from the outset. Inferred from the firm's website | 2024 | $504.7M (Form D) | Open, writing first checks |
| venBio Global Strategic Fund IV, L.P. | 2021 | $549.94M to $550M (Form D) | Follow-ons only |
03 · People across funds
- Aaron Royston, Managing Partner
venBio Global Strategic Fund V, L.P. (Named on Form D); venBio Global Strategic Fund IV, L.P. (Named on Form D)
- Antoinette Delhonte
venBio Global Strategic Fund V, L.P. (Named on Form D)
- Corey Goodman, Co-founder and Managing Partner
venBio Global Strategic Fund V, L.P. (Named on Form D); venBio Global Strategic Fund IV, L.P. (Named on Form D)
- David Pezeshki
venBio Global Strategic Fund V, L.P. (Named on Form D); venBio Global Strategic Fund IV, L.P. (Named on Form D)
- Richard Gaster, Managing Partner
venBio Global Strategic Fund V, L.P. (Named on Form D); venBio Global Strategic Fund IV, L.P. (Named on Form D)
- Robert Adelman, Co-founder and Emeritus Managing Partner
venBio Global Strategic Fund IV, L.P. (Named on Form D)
- Yvonne Yamanaka, Partner
venBio Global Strategic Fund V, L.P. (Named on Form D)
- Aaron Royston, MD, MBA, Managing Partner
venBio Global Strategic Fund V, L.P. (Team); venBio Global Strategic Fund IV, L.P. (Team)
- Corey Goodman, PhD, Co-founder and Managing Partner
venBio Global Strategic Fund V, L.P. (Team); venBio Global Strategic Fund IV, L.P. (Team)
- Daniel Teichmann, Controller
venBio Global Strategic Fund V, L.P. (Team); venBio Global Strategic Fund IV, L.P. (Team)
- David Pezeshki, CFA, CPA, Chief Financial Officer
venBio Global Strategic Fund V, L.P. (Team); venBio Global Strategic Fund IV, L.P. (Team)
- Parthiv Patel, Analyst
venBio Global Strategic Fund V, L.P. (Team); venBio Global Strategic Fund IV, L.P. (Team)
- Richard Gaster, MD, PhD, Managing Partner
venBio Global Strategic Fund V, L.P. (Team); venBio Global Strategic Fund IV, L.P. (Team)
- Robert Adelman, MD, Co-founder and Emeritus Managing Partner
venBio Global Strategic Fund V, L.P. (Team); venBio Global Strategic Fund IV, L.P. (Team)
- Yvonne Yamanaka, PhD, Partner
venBio Global Strategic Fund V, L.P. (Team); venBio Global Strategic Fund IV, L.P. (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- HTTP://WWW.VENBIO.COM
- https://www.venbio.com/contact/
- https://www.venbio.com/press/
- https://www.venbio.com/team/
- https://www.venbio.com/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026